This webinar will clarify the best practices and misconceptions around direct-to-patient (DTP) programs. We’ll address common myths, explaining how these programs operate and deliver impact, with a focus on understanding patients’ needs and expectations in today’s healthcare landscape, how DTP supports early intervention and sustained care, detailed insights into telehealth, lab testing, and prescription fulfillment, and navigating compliance and addressing implementation complexities.
Our panel of thought leaders share expert perspectives on optimizing DTP initiatives and improving patient outcomes: Matthew Walsh (General Manager Biopharma, ixlayer), Mark Gaydos (Regulatory Expert, former Sanofi), Eric McCulley (Head of Portfolio Innovation; US Immunology, UCB), Chad Meader (Senior Director, Patient Experience and Operations CNS/Neurology, Otsuka Precision Health), and Nandini Nayar (Global Digital Health and Innovation Lead, Sanofi).